Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor

[1]  T. Molinski,et al.  Bastadins relate ryanodine-sensitive and -insensitive Ca2+ efflux pathways in skeletal SR and BC3H1 cells. , 1997, The American journal of physiology.

[2]  A. Marks.  Cellular functions of immunophilins. , 1996, Physiological reviews.

[3]  M. Boyd,et al.  Isolation and X-ray crystal structure of racemic Xestospongin D from the Singapore marine sponge Niphates sp1 , 1996 .

[4]  L. Costa,et al.  Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. , 1996, European journal of pharmacology.

[5]  K. Wilson,et al.  Inhibition of nuclear vesicle fusion by antibodies that block activation of inositol 1,4,5-trisphosphate receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Hoye,et al.  Conformational Considerations in 1-Oxaquinolizidines Related to the Xestospongin/Araguspongine Family: Reassignment of Stereostructures for Araguspongines B and E. [Erratum to document cited in CA122:133488] , 1995 .

[7]  S. Snyder,et al.  Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Marks,et al.  The Human Type 1 Inositol 1,4,5-Trisphosphate Receptor from T Lymphocytes , 1995, The Journal of Biological Chemistry.

[9]  R. Duvoisin,et al.  The metabotropic glutamate receptors: Structure and functions , 1995, Neuropharmacology.

[10]  E. Glusa,et al.  Involvement of inositol 1,4,5-triphosphate and protein kinase C in thrombin-induced contraction of porcine pulmonary artery. , 1995, Biochemical pharmacology.

[11]  T. Hoye,et al.  Conformational Considerations in 1-Oxaquinolizidines Related to the Xestospongin/Araguspongine Family: Reassignment of Stereostructures for Araguspongines B and E , 1994 .

[12]  K. Mikoshiba,et al.  Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization. , 1994, The Biochemical journal.

[13]  E. Hamel,et al.  Cholinergic Dilatation and Constriction of Feline Cerebral Blood Vessels Are Mediated by Stimulation of Phosphoinositide Metabolism via Two Different Muscarinic Receptor Subtypes , 1994, Journal of neurochemistry.

[14]  J. Arrang.  Pharmacological properties of histamine receptor subtypes. , 1994, Cellular and molecular biology.

[15]  A. Maranto.  Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. , 1994, The Journal of biological chemistry.

[16]  I. Pessah,et al.  Regulation of inositol 1,4,5-trisphosphate receptors in rat basophilic leukemia cells. I. Multiple conformational states of the receptor in a microsomal preparation. , 1993, Biochimica et biophysica acta.

[17]  I. Bezprozvanny,et al.  Activation of the calcium release channel (ryanodine receptor) by heparin and other polyanions is calcium dependent. , 1993, Molecular biology of the cell.

[18]  V. Briner,et al.  Bradykinin: potential for vascular constriction in the presence of endothelial injury. , 1993, The American journal of physiology.

[19]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[20]  C. Debitus,et al.  Two new alkaloids from Xestospongia sp., a New Caledonian sponge. , 1992, Journal of natural products.

[21]  S. Snyder,et al.  Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Südhof,et al.  Structure of a novel InsP3 receptor. , 1991, The EMBO journal.

[23]  E. Clementi,et al.  Intracellular Ca2+ pools in PC12 cells. A unique, rapidly exchanging pool is sensitive to both inositol 1,4,5-trisphosphate and caffeine-ryanodine. , 1991, The Journal of biological chemistry.

[24]  E. Clementi,et al.  Intracellular Ca2+ pools in PC12 cells. Three intracellular pools are distinguished by their turnover and mechanisms of Ca2+ accumulation, storage, and release. , 1991, The Journal of biological chemistry.

[25]  K. Mikoshiba,et al.  Involvement of the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca2+ release analysed using region-specific monoclonal antibodies. , 1991, The Biochemical journal.

[26]  K. Mikoshiba,et al.  Immunohistochemical localization of an inositol 1,4,5-trisphosphate receptor, P400, in neural tissue: studies in developing and adult mouse brain , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  T. Südhof,et al.  Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. , 1990, The Journal of biological chemistry.

[28]  T. Südhof,et al.  Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor , 1989, Nature.

[29]  Teiichi Furuichi,et al.  Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400 , 1989, Nature.

[30]  K. Kawazoe,et al.  Araguspongines B, C, D, E, F, G, H, and J, new vasodilative bis-1-oxaquinolizidine alkaloids from an okinawan marine sponge, Xestospongia sp. , 1989, Chemical & pharmaceutical bulletin.

[31]  H. Takeshima,et al.  Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor , 1989, Nature.

[32]  J. Mullaney,et al.  Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. , 1988, Journal of Biological Chemistry.

[33]  S. Kobayashi,et al.  Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. , 1988, Biochemical and biophysical research communications.

[34]  J. Casida,et al.  Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. , 1987, Molecular pharmacology.

[35]  M. Endo,et al.  Pharmacologically active substances from southern Pacific marine invertebrates , 1986 .

[36]  S. Fleischer,et al.  Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle , 1984, The Journal of cell biology.

[37]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.

[38]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[39]  A. Tinker,et al.  Measuring the length of the pore of the sheep cardiac sarcoplasmic reticulum calcium-release channel using related trimethylammonium ions as molecular calipers. , 1995, Biophysical journal.

[40]  E. Glusa,et al.  Inositol 1,4,5-triphosphate and protein kinase C are involved in thrombin- and trap-induced vascular smooth muscle contraction. , 1995, Agents and actions. Supplements.

[41]  J Ellis,et al.  Structure/function relationships of muscarinic acetylcholine receptors. , 1993, Life sciences.

[42]  J. Meldolesi,et al.  [Ca2+]i effects of bradykinin B2 receptor activation in PC12 cells. , 1992, Agents and actions. Supplements.

[43]  M. Endo,et al.  Structures of xestospongin A,B,C and D, novel vasodilativecompounds from marine sponge, , 1984 .